Autonomic Nervous System Drugs Practice Questions

Q: Which of the following drugs is a selective antagonist of M1 muscarinic receptors?

Pirenzepine. ### Explanation **Correct Answer: D. Pirenzepine** **1. Why Pirenzepine is Correct:** Muscarinic receptors are classified into five subtypes ($M_1$ to $M_5$). **Pirenzepine** (and its analog Telenzepine) is a selective **$M_1$ receptor antagonist**. $M_1$ receptors are primarily located in the gastric glands (oxyntic cells) and autonomic ganglia. By blocking these receptors, Pirenzepine reduces gastric acid secretion. While historically used for peptic ulcer disease, it has largely been replaced by $H_2$ blockers and Proton Pump Inhibitors (PPIs). **2. Analysis of Incorrect Options:** * **A. Methacholine:** This is a non-selective **muscarinic agonist** (cholinomimetic). It is primarily used in the "Methacholine Challenge Test" to diagnose bronchial hyperreactivity in suspected asthma. * **B. Bethanechol:** This is a selective **muscarinic agonist** with significant action on the bladder and GI tract. It is used clinically to treat post-operative urinary retention and paralytic ileus. * **C. Methoctramine:** This is a selective **$M_2$ receptor antagonist**. $M_2$ receptors are predominantly found in the heart; blocking them leads to tachycardia. **3. High-Yield NEET-PG Pearls:** * **M1 Selective Antagonists:** Pirenzepine, Telenzepine (used for Peptic Ulcers). * **M2 Selective Antagonist:** Methoctramine, Gallamine. * **M3 Selective Antagonist:** Darifenacin, Solifenacin (used for Overactive Bladder/Urge Incontinence). * **M3 Selective Agonist:** Cevimeline (used for Sjögren’s syndrome to increase salivation). * **Ipratropium/Tiotropium:** Non-selective muscarinic antagonists used via inhalation for COPD/Asthma to cause bronchodilation.

Q: Which non-selective beta blocker is commonly used in the management of glaucoma?

Timolol. **Explanation:** **Timolol** is the gold standard and most commonly used non-selective beta-blocker in the management of Open-Angle Glaucoma. It works by blocking $\beta_2$ receptors on the **ciliary epithelium**, thereby reducing the production of aqueous humor. Since it does not affect pupil size or accommodation, it is preferred over miotics. **Analysis of Options:** * **Timolol (Correct):** A potent non-selective $\beta_1$ and $\beta_2$ blocker. It is highly effective in lowering intraocular pressure (IOP) but must be used with caution in patients with asthma or COPD due to potential systemic absorption causing bronchospasm. * **Metoprolol:** This is a cardioselective ($\beta_1$) blocker primarily used in systemic hypertension and cardiology; it is not used topically for glaucoma. * **Betaxolol:** This is a **cardioselective ($\beta_1$)** beta-blocker. While used in glaucoma, it is less effective at lowering IOP than Timolol. However, it is the safest topical beta-blocker for patients with mild respiratory issues because it lacks $\beta_2$ antagonist activity. * **Propranolol:** Although a non-selective beta-blocker, it possesses significant local anesthetic (membrane-stabilizing) activity, which can cause corneal anesthesia and damage if applied topically. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Decreased aqueous secretion (not increased outflow). * **Side Effects:** Bradycardia, heart block, and bronchospasm (due to systemic absorption via the nasolacrimal duct). * **Tip:** To minimize systemic absorption, patients should be advised to perform **punctal occlusion** for 2 minutes after instillation. * **Contraindications:** Bronchial asthma, COPD, 2nd/3rd-degree heart block, and overt heart failure.

Q: Alpha-2 adrenergic agonists cause all of the following effects except:

Hyperalgesia. **Explanation:** Alpha-2 ($\alpha_2$) adrenergic agonists (such as **Clonidine** and **Dexmedetomidine**) act primarily by inhibiting the release of norepinephrine through a negative feedback mechanism at presynaptic nerve terminals. **Why Hyperalgesia is the Correct Answer:** Hyperalgesia refers to an increased sensitivity to pain. $\alpha_2$ agonists are known for their **antinociceptive** properties, meaning they decrease pain perception rather than increasing it. They achieve this by stimulating $\alpha_2$ receptors in the dorsal horn of the spinal cord, which inhibits the release of substance P and other pro-nociceptive neurotransmitters [3]. Therefore, they cause analgesia, not hyperalgesia. **Analysis of Incorrect Options:** * **Analgesia:** As mentioned, $\alpha_2$ agonists provide potent adjunctive pain relief by modulating pain pathways in the spinal cord and brainstem [3]. * **Sedation:** These drugs act on the **locus coeruleus** (the primary noradrenergic nucleus in the brainstem) to decrease sympathetic outflow, leading to a "natural-like" sleep state from which patients can be easily aroused [1], [3]. * **Anxiolysis:** By reducing central sympathetic activity and norepinephrine levels, $\alpha_2$ agonists effectively reduce anxiety and are often used as pre-anesthetic medications. **NEET-PG High-Yield Pearls:** * **Dexmedetomidine:** A highly selective $\alpha_2$ agonist used for ICU sedation; it causes minimal respiratory depression compared to opioids or benzodiazepines [3]. * **Clonidine:** Used in hypertension, opioid withdrawal, and ADHD [4]. * **Side Effects:** The most common side effects are **bradycardia** and **hypotension** due to decreased central sympathetic tone [1], [2]. * **Mechanism:** They are G-protein coupled receptors ($G_i$) that inhibit adenylyl cyclase, leading to decreased cAMP.

Q: What is mirabegron?

Beta 3 agonist. **Explanation:** **Mirabegron** is a potent and selective **Beta-3 ($\beta_3$) adrenergic receptor agonist**. In the context of neuroanatomy and autonomic pharmacology, $\beta_3$ receptors are primarily located on the **detrusor muscle** of the urinary bladder. Activation of these receptors stimulates adenylyl cyclase, increasing intracellular cAMP, which leads to detrusor muscle relaxation [1]. This increases bladder capacity and provides symptomatic relief for **Overactive Bladder (OAB)** without the dry mouth and constipation typically associated with anticholinergics. **Analysis of Incorrect Options:** * **Option A (Alpha-2 agonist):** These agents (e.g., Clonidine) act on presynaptic receptors in the CNS to decrease sympathetic outflow. They are used for hypertension or sedation, not bladder relaxation. * **Option C (Beta-1 agonist):** These receptors are primarily located in the heart. Agonists (e.g., Dobutamine) increase heart rate and contractility [1]. * **Option D (Beta-2 agonist):** These receptors are found in bronchial smooth muscle. Agonists (e.g., Salbutamol) are used for bronchodilation in asthma/COPD. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Use:** First-line alternative for Overactive Bladder (OAB) in patients who cannot tolerate antimuscarinics (like Oxybutynin). * **Side Effects:** The most significant side effect is **Hypertension**; it should be avoided in patients with severe uncontrolled high blood pressure. * **Mechanism:** It enhances the "filling/storage" phase of micturition by mimicking sympathetic stimulation of the detrusor.

Q: Which mydriatic agent has no cycloplegic effect?

Phenylephrine. **Explanation:** To understand why **Phenylephrine** is the correct answer, we must distinguish between the two different muscle groups in the eye responsible for pupillary changes: 1. **Dilator Pupillae (Radial muscle):** Controlled by the **Sympathetic** nervous system ($\alpha_1$ receptors). Stimulation causes mydriasis (dilation) without affecting the lens. 2. **Sphincter Pupillae & Ciliary Muscle:** Controlled by the **Parasympathetic** nervous system (M$_3$ receptors). Blocking these causes both mydriasis and **cycloplegia** (paralysis of accommodation). **Why Phenylephrine is correct:** Phenylephrine is a selective **$\alpha_1$-adrenergic agonist**. It acts directly on the dilator pupillae muscle to produce mydriasis. Since it has no effect on the cholinergic receptors of the ciliary muscle, it **does not cause cycloplegia**. This makes it ideal for routine fundus examinations where the patient needs to maintain the ability to focus on near objects. **Why the other options are incorrect:** * **Atropine, Tropicamide, and Homatropine** are all **Antimuscarinic (Anticholinergic) agents**. They block M$_3$ receptors on both the sphincter pupillae (causing mydriasis) and the ciliary muscle (causing cycloplegia). Therefore, they are "cycloplegic mydriatics." **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for Fundoscopy:** Tropicamide (fastest onset, shortest duration among antimuscarinics). * **Drug of choice for Iridocyclitis:** Atropine (prevents synechiae and provides rest to the ciliary muscle, reducing pain). * **Phenylephrine Caution:** It can cause a transient rise in blood pressure and should be used cautiously in hypertensive patients. It is also used to differentiate between scleritis and episcleritis (it blanches episcleral vessels). * **Mnemonic:** **S**ympathetic = **S**pares the ciliary muscle (No cycloplegia).

Q: Which of the following antiglaucoma drugs can lead to drowsiness?

Brimonidine. **Explanation:** **Brimonidine** is a highly selective **Alpha-2 (α2) adrenergic agonist**. Unlike its predecessor, Apraclonidine, Brimonidine is more lipophilic, allowing it to cross the **blood-brain barrier (BBB)**. Once in the central nervous system, it stimulates α2 receptors in the brainstem, leading to a reduction in sympathetic outflow. This central action commonly results in **drowsiness, fatigue, and lethargy**. Due to this CNS penetration, Brimonidine is strictly **contraindicated in children under 2 years of age**, as it can cause life-threatening apnea, bradycardia, and profound sedation (somnolence). **Analysis of Incorrect Options:** * **Apraclonidine:** While also an α2 agonist, it is more polar and does not cross the BBB effectively. Its primary side effects are local (allergic blepharoconjunctivitis). * **Dipivefrin:** A prodrug of epinephrine (non-selective α and β agonist). It is more likely to cause systemic sympathetic effects like tachycardia or arrhythmias rather than drowsiness. * **Timolol:** A non-selective β-blocker. Its systemic side effects are primarily cardiovascular (bradycardia) and respiratory (bronchospasm), not typically drowsiness. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Brimonidine reduces IOP by both decreasing aqueous humor production and increasing uveoscleral outflow. * **Neuroprotection:** It is often cited as having potential neuroprotective properties for the optic nerve. * **Follicular Conjunctivitis:** This is the most common local side effect of Brimonidine. * **Contraindication:** Avoid in patients taking Monoamine Oxidase Inhibitors (MAOIs) due to the risk of hypertensive crisis.

Q: Which direct-acting cholinomimetic, being lipid-soluble, has been used in the treatment of glaucoma?

Pilocarpine. ### Explanation **Correct Option: C. Pilocarpine** Pilocarpine is a **direct-acting cholinomimetic** alkaloid that acts primarily on Muscarinic ($M_3$) receptors [2]. It is a tertiary amine, making it **lipid-soluble** and capable of penetrating the cornea effectively [2]. In glaucoma, it causes contraction of the ciliary muscle (increasing aqueous outflow through the trabecular meshwork) and the sphincter pupillae (causing miosis) [1]. This makes it a classic drug for treating both open-angle and acute angle-closure glaucoma [1]. **Analysis of Incorrect Options:** * **A. Acetylcholine:** While it is a direct-acting agonist, it is a quaternary ammonium compound (polar/water-soluble) with an extremely short half-life due to rapid degradation by pseudocholinesterase. It is not used clinically for glaucoma. * **B. Physostigmine:** Although it is lipid-soluble and used in glaucoma, it is an **indirect-acting** cholinomimetic (acetylcholinesterase inhibitor), not a direct-acting one. * **D. Neostigmine:** This is an indirect-acting cholinomimetic and a quaternary ammonium compound. Being **water-soluble (polar)**, it does not penetrate the cornea or the blood-brain barrier effectively. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** Pilocarpine is the DOC for the emergency management of **Acute Angle-Closure Glaucoma** (to break the pupillary block) [1]. * **Side Effects:** A common side effect is "brow ache" due to ciliary muscle spasm and fixed small pupils (difficulty seeing in the dark). * **Adie’s Tonic Pupil:** Diagnosis is confirmed using **dilute pilocarpine (0.125%)**, which causes constriction in the affected eye due to cholinergic supersensitivity. * **Sjögren’s Syndrome:** Oral pilocarpine is used to treat xerostomia (dry mouth) [2].

Q: Anti-muscarinic drugs are used for all of the following indications EXCEPT?

Hypertension. **Explanation:** **1. Why Hypertension is the Correct Answer:** Anti-muscarinic drugs (like Atropine) block M2 receptors in the heart and M3 receptors in the vasculature. Blocking M2 receptors leads to **tachycardia** (increased heart rate), which can actually increase cardiac output and blood pressure. Furthermore, anti-muscarinics have no role in lowering peripheral resistance. Therefore, they are **contraindicated** or ineffective in hypertension. In fact, they are used to treat *bradycardia* and *hypotension* (e.g., Atropine in ACLS). **2. Why the Other Options are Incorrect (Indications for Use):** * **Motion Sickness:** Centrally acting anti-muscarinics like **Scopolamine (Hyoscine)** block M1 receptors in the vestibular apparatus and vomiting center, making them the drug of choice for prophylaxis. * **Parkinson’s Disease:** Centrally acting agents like **Trihexyphenidyl (Benzhexol)** and **Benztropine** are used to correct the cholinergic-dopaminergic imbalance, specifically helping with tremors and rigidity. * **Mydriasis and Cycloplegia:** Drugs like **Atropine, Homatropine, and Cyclopentolate** block M3 receptors on the sphincter pupillae (causing mydriasis) and the ciliary muscle (causing cycloplegia/paralysis of accommodation). This is essential for accurate refractive testing and fundus examination. **Clinical Pearls for NEET-PG:** * **Drug of choice for Mushroom poisoning (Mycetism):** Atropine. * **Ipratropium/Tiotropium:** M3 blockers used as bronchodilators in COPD and Asthma. * **Oxybutynin/Darifenacin:** M3 selective blockers used for Overactive Bladder (Urge incontinence). * **Contraindication:** Anti-muscarinics must be avoided in patients with **Angle-closure Glaucoma** and **Benign Prostatic Hyperplasia (BPH)**.

Question 1

Which of the following drugs is a selective antagonist of M1 muscarinic receptors?

Accepted Answer

Pirenzepine

Answer

Methacholine

Answer

Bethanechol

Answer

Methoctramine

Question 2

Which non-selective beta blocker is commonly used in the management of glaucoma?

Accepted Answer

Timolol

Answer

Metoprolol

Answer

Betaxolol

Answer

Propranolol

Question 3

Alpha-2 adrenergic agonists cause all of the following effects except:

Accepted Answer

Hyperalgesia

Answer

Analgesia

Answer

Sedation

Answer

Anxiolysis

Question 4

What is mirabegron?

Accepted Answer

Beta 3 agonist

Answer

Alpha 2 agonist

Answer

Beta 1 agonist

Answer

Beta 2 agonist

Question 5

Which mydriatic agent has no cycloplegic effect?

Accepted Answer

Phenylephrine

Answer

Atropine

Answer

Tropicamide

Answer

Homatropine

Question 6

Which of the following antiglaucoma drugs can lead to drowsiness?

Accepted Answer

Brimonidine

Answer

Apraclonidine

Answer

Dipevefrine

Answer

Timolol

Question 7

Which direct-acting cholinomimetic, being lipid-soluble, has been used in the treatment of glaucoma?

Accepted Answer

Pilocarpine

Answer

Acetylcholine

Answer

Physostigmine

Answer

Neostigmine

Question 8

Pancuronium differs from tubocurarine in which of the following aspects?

Accepted Answer

It can cause a rise in blood pressure on rapid intravenous injection.

Answer

It is a depolarizing blocker.

Answer

Its action is not reversed by neostigmine.

Answer

It causes marked histamine release.

Question 9

What is the mechanism of action of curare?

Accepted Answer

Reducing end-plate potential

Answer

Reducing presynaptic potential

Answer

Inhibiting channels

Answer

Inhibiting Na+ channels

Question 10

Anti-muscarinic drugs are used for all of the following indications EXCEPT?

Accepted Answer

Hypertension

Answer

Motion sickness

Answer

Parkinson's disease

Answer

To produce mydriasis and cycloplegia

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?